Cargando…

Developing BET-ter treatments for cutaneous T-cell lymphoma

Detalles Bibliográficos
Autor principal: Wong, Henry K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407685/
https://www.ncbi.nlm.nih.gov/pubmed/30863486
http://dx.doi.org/10.18632/oncotarget.26662
_version_ 1783401610737614848
author Wong, Henry K.
author_facet Wong, Henry K.
author_sort Wong, Henry K.
collection PubMed
description
format Online
Article
Text
id pubmed-6407685
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-64076852019-03-12 Developing BET-ter treatments for cutaneous T-cell lymphoma Wong, Henry K. Oncotarget News Impact Journals LLC 2019-02-12 /pmc/articles/PMC6407685/ /pubmed/30863486 http://dx.doi.org/10.18632/oncotarget.26662 Text en Copyright: © 2019 Wong. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle News
Wong, Henry K.
Developing BET-ter treatments for cutaneous T-cell lymphoma
title Developing BET-ter treatments for cutaneous T-cell lymphoma
title_full Developing BET-ter treatments for cutaneous T-cell lymphoma
title_fullStr Developing BET-ter treatments for cutaneous T-cell lymphoma
title_full_unstemmed Developing BET-ter treatments for cutaneous T-cell lymphoma
title_short Developing BET-ter treatments for cutaneous T-cell lymphoma
title_sort developing bet-ter treatments for cutaneous t-cell lymphoma
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407685/
https://www.ncbi.nlm.nih.gov/pubmed/30863486
http://dx.doi.org/10.18632/oncotarget.26662
work_keys_str_mv AT wonghenryk developingbettertreatmentsforcutaneoustcelllymphoma